封面
市场调查报告书
商品编码
1259796

醣质学/糖生物学市场:占有率,规模,趋势,产业分析报告,各产品,各用途,各最终用途,各地区,各市场区隔预测,2023年~2032年

Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymes, Kits, Reagents, and Instruments); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032

出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

全球醣质学/糖生物学的市场规模到2032年前将达到52亿4,000万美元。

本报告提供全球醣质学/糖生物学市场相关调查,提供各产品,各用途,各最终用途,各地区趋势,及加入此市场的主要企业简介等资讯。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球醣质学/糖生物学市场洞察

  • 醣质学/糖生物学市场- 各最终用途概述
  • 醣质学/糖生物学市场动态
  • 波特的五力分析
  • PESTEL分析
  • 醣质学/糖生物学市场最终用途趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球醣质学/糖生物学市场,各产品

  • 主要调查结果
  • 简介
    • 全球醣质学/糖生物学市场,各产品,2019年~2032年(10亿美元)
  • 酵素
  • 套件
  • 试剂
  • 设备

第6章 全球醣质学/糖生物学市场,各用途

  • 主要调查结果
  • 简介
    • 全球醣质学/糖生物学市场,各用途,2019年~2032年(10亿美元)
  • 药物研发与开发
  • 诊断
  • 其他

第7章 全球醣质学/糖生物学市场,各最终用途

  • 主要调查结果
  • 简介
    • 全球醣质学/糖生物学市场,各最终用途,2019年~2032年(10亿美元)
  • 学术·研究机关
  • 製药公司·生物科技企业
  • CRO

第8章 全球醣质学/糖生物学市场,各地区

  • 主要调查结果
  • 简介
    • 醣质学/糖生物学市场评估,各地区,2019年~2032年(10亿美元)
  • 醣质学/糖生物学市场-北美
  • 醣质学/糖生物学市场-欧洲
  • 醣质学/糖生物学市场-亚太地区
  • 醣质学/糖生物学市场-中东·非洲
  • 醣质学/糖生物学市场-南美

第9章 竞争情形

第10章 企业简介

  • Thermo Fisher Scientific
  • Merck
  • Agilent Technology
  • New England Biolabs
  • Danaher Corporation
  • Shimadzu Corporation
  • Takara Bio
  • Waters Corporation
  • Sumitomo Bakelite
  • AMS Bio
  • Kode Biotech
  • Ray Biotech Life
  • Lectenz Bio
  • Glycomix
  • Ludger
  • Glyxera
  • IEC Group
Product Code: PM3047

The global glycomics/glycobiology market size is expected to reach USD 5.24 billion by 2032, according to a new study by Polaris Market Research. The report "Glycomics/Glycobiology Market Share, Size, Trends, Industry Analysis Report, By Product (Enzymes, Kits, Reagents, and Instruments); By Application; By End-Use; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Rising investments and implementation on glycomics research by both government and private organizations, high development of many novel drugs & therapeutics, and progress in proteomics are key factors boosting global market growth.

In the last decades, glycomics has gained high popularity as an emerging field of research and has a wide range of applications in oncology, diagnostics, drug discovery, and immunology and is also being used in determining cancer cells and regulating cell regulation. Thus, the market is expected to grow significantly and have huge opportunities shortly. For instance, in April 2022, Bruker announced the availability of its new novel MALDI HiPLEX-IHC tissue imaging solution for timsTOF flex combined with unbiased lipidomics, metabolomics, and glycomics tissue imaging.

The growing prevalence of cancer and other related diseases among people worldwide has led to the rising use of glycobiology in research activities for cancer treatment, because of the relevance of surface glycan in both neoplastic and metastatic characteristics of tumor cells present in human body. Lung cancer amounted to a leading number of cancer deaths, with a total estimated 1.8 million deaths followed by colorectal with about 1 million deaths.

Furthermore, precision medicine has rapidly grown in recent years and many large pharma and biotech companies are investing larger funds to develop various targeted drugs, which can be effectively used for a specific patient group. In addition, a researcher has also shown that the mutation in glycosyltransferases or other related enzymes alters the glycome and also causes over 100 types of human congenital disorders.

Glycomics/Glycobiology Market Report Highlights:

Instruments segment accounted for largest market share in 2022 on account of increasing adoption of innovative instruments across various applications including diagnostics

Drug discovery & development segment held the largest market revenue share in 2022, owing to the increase in prevalence of personalized medicine to address chronic diseases

Pharmaceutical & biotechnology companies are likely to be the largest end-use segment over the forecast period due to the increased investment and efforts by the companies on technology development and product enhancement.

North America dominated the global market in 2022, which is highly attributed to the growing proliferation of precision medicine and increasing healthcare spending in countries like the US and Canada.

The global key market players include Thermo Fisher Scientific, Agilent Technology, New England Biolabs, Sumitomo Bakelite, and Danaher Corporation

Polaris Market Research has segmented the glycomics/glycobiology market report based on product, application, end-use, and region:

Glycomics/Glycobiology, Product Outlook (Revenue - USD Billion, 2019 - 2032)

Enzymes

Kits

Reagents

Instruments

Glycomics/Glycobiology, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Drug Discovery & Development

Diagnostics

Others

Glycomics/Glycobiology, End-Use Outlook (Revenue - USD Billion, 2019 - 2032)

Academic & Research Institute

Pharmaceutical & Biotechnology Companies

CROs

Glycomics/Glycobiology, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Glycomics/Glycobiology Market Insights

  • 4.1. Glycomics/Glycobiology Market - End Use Snapshot
  • 4.2. Glycomics/Glycobiology Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Technological advancements
      • 4.2.1.2. Rising investments in R&D of pharmaceutical and biotechnology companies
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of tools
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Glycomics/Glycobiology Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Glycomics/Glycobiology Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Enzymes
    • 5.3.1. Global Glycomics/Glycobiology Market, by Enzymes, by Region, 2019-2032 (USD Billion)
  • 5.4. Kits
    • 5.4.1. Global Glycomics/Glycobiology Market, by Kits, by Region, 2019-2032 (USD Billion)
  • 5.5. Reagents
    • 5.5.1. Global Glycomics/Glycobiology Market, Reagents, by Region, 2019-2032 (USD Billion)
  • 5.6. Instruments
    • 5.6.1. Global Glycomics/Glycobiology Market, Instruments, by Region, 2019-2032 (USD Billion)

6. Global Glycomics/Glycobiology Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • 6.3. Drug Discovery & Development
    • 6.3.1. Global Glycomics/Glycobiology Market, by Drug Discovery & Development, by Region, 2019-2032 (USD Billion)
  • 6.4. Diagnostics
    • 6.4.1. Global Glycomics/Glycobiology Market, by Diagnostics, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Glycomics/Glycobiology Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Glycomics/Glycobiology Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • 7.3. Academic & Research Institute
    • 7.3.1. Global Glycomics/Glycobiology Market, by Academic & Research Institute, By Region, 2019-2032 (USD Billion)
  • 7.4. Pharmaceutical & Biotechnology Companies
    • 7.4.1. Global Glycomics/Glycobiology Market, by Pharmaceutical & Biotechnology Companies, By Region, 2019-2032 (USD Billion)
  • 7.5. CROS
    • 7.5.1. Global Glycomics/Glycobiology Market, by CROS, By Region, 2019-2032 (USD Billion)

8. Global Glycomics/Glycobiology Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Glycomics/Glycobiology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Glycomics/Glycobiology Market - North America
    • 8.3.1. North America: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4. Glycomics/Glycobiology Market - U.S.
      • 8.3.4.1. U.S.: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5. Glycomics/Glycobiology Market - Canada
      • 8.3.5.1. Canada: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • 8.4. Glycomics/Glycobiology Market - Europe
    • 8.4.1. Europe: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4. Glycomics/Glycobiology Market - UK
      • 8.4.4.1. UK: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5. Glycomics/Glycobiology Market - France
      • 8.4.5.1. France: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6. Glycomics/Glycobiology Market - Germany
      • 8.4.6.1. Germany: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7. Glycomics/Glycobiology Market - Italy
      • 8.4.7.1. Italy: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8. Glycomics/Glycobiology Market - Spain
      • 8.4.8.1. Spain: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9. Glycomics/Glycobiology Market - Netherlands
      • 8.4.9.1. Netherlands: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10. Glycomics/Glycobiology Market - Russia
      • 8.4.10.1. Russia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • 8.5. Glycomics/Glycobiology Market - Asia Pacific
    • 8.5.1. Asia Pacific: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4. Glycomics/Glycobiology Market - China
      • 8.5.4.1. China: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5. Glycomics/Glycobiology Market - India
      • 8.5.5.1. India: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6. Glycomics/Glycobiology Market - Malaysia
      • 8.5.6.1. Malaysia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7. Glycomics/Glycobiology Market - Japan
      • 8.5.7.1. Japan: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8. Glycomics/Glycobiology Market - Indonesia
      • 8.5.8.1. Indonesia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9. Glycomics/Glycobiology Market - South Korea
      • 8.5.9.1. South Korea: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • 8.6. Glycomics/Glycobiology Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4. Glycomics/Glycobiology Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5. Glycomics/Glycobiology Market - UAE
      • 8.6.5.1. UAE: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6. Glycomics/Glycobiology Market - Israel
      • 8.6.6.1. Israel: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7. Glycomics/Glycobiology Market - South Africa
      • 8.6.7.1. South Africa: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • 8.7. Glycomics/Glycobiology Market - Latin America
    • 8.7.1. Latin America: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4. Glycomics/Glycobiology Market - Mexico
      • 8.7.4.1. Mexico: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5. Glycomics/Glycobiology Market - Brazil
      • 8.7.5.1. Brazil: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6. Glycomics/Glycobiology Market - Argentina
      • 8.7.6.1. Argentina: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Thermo Fisher Scientific
    • 10.1.1. Company Overview
    • 10.1.2. Financial PerApplicationance
    • 10.1.3. Application Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Merck
    • 10.2.1. Company Overview
    • 10.2.2. Financial PerApplicationance
    • 10.2.3. Application Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Agilent Technology
    • 10.3.1. Company Overview
    • 10.3.2. Financial PerApplicationance
    • 10.3.3. Application Benchmarking
    • 10.3.4. Recent Development
  • 10.4. New England Biolabs
    • 10.4.1. Company Overview
    • 10.4.2. Financial PerApplicationance
    • 10.4.3. Application Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Danaher Corporation
    • 10.5.1. Company Overview
    • 10.5.2. Financial PerApplicationance
    • 10.5.3. Application Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Shimadzu Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial PerApplicationance
    • 10.6.3. Application Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Takara Bio
    • 10.7.1. Company Overview
    • 10.7.2. Financial PerApplicationance
    • 10.7.3. Application Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Waters Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial PerApplicationance
    • 10.8.3. Application Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sumitomo Bakelite
    • 10.9.1. Company Overview
    • 10.9.2. Financial PerApplicationance
    • 10.9.3. Application Benchmarking
    • 10.9.4. Recent Development
  • 10.10. AMS Bio
    • 10.10.1. Company Overview
    • 10.10.2. Financial PerApplicationance
    • 10.10.3. Application Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Kode Biotech
    • 10.11.1. Company Overview
    • 10.11.2. Financial PerApplicationance
    • 10.11.3. Application Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Ray Biotech Life
    • 10.12.1. Company Overview
    • 10.12.2. Financial PerApplicationance
    • 10.12.3. Application Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Lectenz Bio
    • 10.13.1. Company Overview
    • 10.13.2. Financial PerApplicationance
    • 10.13.3. Application Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Glycomix
    • 10.14.1. Company Overview
    • 10.14.2. Financial PerApplicationance
    • 10.14.3. Application Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Ludger
    • 10.15.1. Company Overview
    • 10.15.2. Financial PerApplicationance
    • 10.15.3. Application Benchmarking
    • 10.15.4. Recent Development
  • 10.16. Glyxera
    • 10.16.1. Company Overview
    • 10.16.2. Financial PerApplicationance
    • 10.16.3. Application Benchmarking
    • 10.16.4. Recent Development
  • 10.17. IEC Group
    • 10.17.1. Company Overview
    • 10.17.2. Financial PerApplicationance
    • 10.17.3. Application Benchmarking
    • 10.17.4. Recent Development

List of Tables

  • Table 1 Global Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 3 Global Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 4 Glycomics/Glycobiology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 7 North America: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 10 U.S.: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 13 Canada: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 16 Europe: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 UK: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 19 UK: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 20 France: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 22 France: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 25 Germany: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 28 Italy: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 31 Spain: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 37 Russia: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 China: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 43 China: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 44 India: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 46 India: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 52 Japan: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 58 South Korea: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 67 UAE: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 70 Israel: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 73 South Africa: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 76 Latin America: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 79 Mexico: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 82 Brazil: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Glycomics/Glycobiology Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Glycomics/Glycobiology Market, by Application, 2019-2032 (USD Billion)
  • Table 85 Argentina: Glycomics/Glycobiology Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Glycomics/Glycobiology Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Glycomics/Glycobiology Market, by Application, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Glycomics/Glycobiology Market, by Product, 2021 & 2030 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Glycomics/Glycobiology Market, by End Use, 2021 & 2030 (USD Billion)
  • Figure 12. Glycomics/Glycobiology Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Glycomics/Glycobiology Market